Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.44 |
| ▸ | RAPGEF3 | O95398 | 6/20 | 0.43 |
| ▸ | RAPGEF4 | Q8WZA2 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | TMPRSS4 | Q9NRS4 | 1/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.38 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4110934 | 1.00 | HTT (0.45) | HTTSMN1; SMN2MAPTLMNATSHR | |
| SCHEMBL4114976 | 0.90 | HTT (0.56) | HTTSMN1; SMN2MAPTLMNATSHR | |
| SCHEMBL4114980 | 0.90 | HTT (0.56) | HTTSMN1; SMN2MAPTLMNATSHR | |
| SCHEMBL4102761 | 0.89 | HTT (0.52) | HTTSMN1; SMN2MAPTLMNATSHR | |
| SCHEMBL4102762 | 0.89 | HTT (0.52) | HTTSMN1; SMN2MAPTLMNATSHR | |
| SCHEMBL4110003 | 0.87 | S1PR3 (0.49) | HTTSMN1; SMN2MAPTLMNATSHR | |
| SCHEMBL4110007 | 0.87 | S1PR3 (0.49) | HTTSMN1; SMN2MAPTLMNATSHR | |
| SCHEMBL4115622 | 0.87 | HTT (0.44) | HTTSMN1; SMN2MAPTLMNATSHR | |
| SCHEMBL4115619 | 0.87 | HTT (0.44) | HTTSMN1; SMN2MAPTLMNATSHR | |
| SCHEMBL4121105 | 0.85 | S1PR3 (0.41) | HTTSMN1; SMN2MAPTLMNARAPGEF3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546452-B2 | S1P3 receptor antagonist | TOA EIYO LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| CN-101282926-B | S1p3 receptor antagonist | TOA EIYO LTD (JP) | 2011-07-13 | — | — | CN | disclosed |
| US-20090170895-A1 | S1P3 RECEPTOR ANTAGONIST | TOA EIYO LTD. (JP) | 2009-07-02 | — | — | US | disclosed |
| CN-101282926-A | S1p3 receptor antagonist | TOA EIYO LTD (JP) | 2008-10-08 | — | — | CN | disclosed |
| EP-1935874-A1 | S1P3 RECEPTOR ANTAGONIST | TOA EIYO LTD. (JP) | 2008-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170895-A1 | S1P3 RECEPTOR ANTAGONIST | S1PR3, S1PR5, GPR3 | HTT 4148/4885SMN1; SMN2 2497/4885MAPT 4848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.